295 related articles for article (PubMed ID: 29479316)
21. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
22. Recent Development of Copolymeric Nano-Drug Delivery System for Paclitaxel.
Chen S; Song Z; Feng R
Anticancer Agents Med Chem; 2020; 20(18):2169-2189. PubMed ID: 32682385
[TBL] [Abstract][Full Text] [Related]
23. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine.
Dhyani P; Quispe C; Sharma E; Bahukhandi A; Sati P; Attri DC; Szopa A; Sharifi-Rad J; Docea AO; Mardare I; Calina D; Cho WC
Cancer Cell Int; 2022 Jun; 22(1):206. PubMed ID: 35655306
[TBL] [Abstract][Full Text] [Related]
24. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines.
Takara K; Sakaeda T; Yagami T; Kobayashi H; Ohmoto N; Horinouchi M; Nishiguchi K; Okumura K
Biol Pharm Bull; 2002 Jun; 25(6):771-8. PubMed ID: 12081145
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
[TBL] [Abstract][Full Text] [Related]
27. A review of small molecules and drug delivery applications using gold and iron nanoparticles.
Jahangirian H; Kalantari K; Izadiyan Z; Rafiee-Moghaddam R; Shameli K; Webster TJ
Int J Nanomedicine; 2019; 14():1633-1657. PubMed ID: 30880970
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Inhibitors of Membrane Traffic from a Panel of Clinically Effective Anticancer Drugs.
Kamata H; Sadahiro S; Yamori T
Biol Pharm Bull; 2019 May; 42(5):814-818. PubMed ID: 30787205
[TBL] [Abstract][Full Text] [Related]
29. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead.
Martino E; Casamassima G; Castiglione S; Cellupica E; Pantalone S; Papagni F; Rui M; Siciliano AM; Collina S
Bioorg Med Chem Lett; 2018 Sep; 28(17):2816-2826. PubMed ID: 30122223
[TBL] [Abstract][Full Text] [Related]
30. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
31. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
Conter V; Beck WT
Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).
Duffy CP; Elliott CJ; O'Connor RA; Heenan MM; Coyle S; Cleary IM; Kavanagh K; Verhaegen S; O'Loughlin CM; NicAmhlaoibh R; Clynes M
Eur J Cancer; 1998 Jul; 34(8):1250-9. PubMed ID: 9849488
[TBL] [Abstract][Full Text] [Related]
33. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent-loaded nanoparticles.
Siddiquee T; Bhaskaran NA; Nathani K; Sawarkar SP
Phytother Res; 2024 May; ():. PubMed ID: 38806412
[TBL] [Abstract][Full Text] [Related]
34. Rationale for non-platinum chemotherapy in advanced NSCLC.
Murren JR
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
[TBL] [Abstract][Full Text] [Related]
35. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
36. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
Uppal S; Italiya KS; Chitkara D; Mittal A
Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery systems and combination therapy by using vinca alkaloids.
Lee CT; Huang YW; Yang CH; Huang KS
Curr Top Med Chem; 2015; 15(15):1491-500. PubMed ID: 25877096
[TBL] [Abstract][Full Text] [Related]
38. Drug Delivery Systems of Betulin and Its Derivatives: An Overview.
Jaroszewski B; Jelonek K; Kasperczyk J
Biomedicines; 2024 May; 12(6):. PubMed ID: 38927375
[TBL] [Abstract][Full Text] [Related]
39. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
